Yaxi Chen

机构：Dalian Medical University, Hawassa University, Second Affiliated Hospital of Chongqing Medical University, Beijing Enterprises (China), The London College, Chongqing Medical and Pharmaceutical College, University College London, Chongqing Medical University · ORCID：0000-0002-6242-7152

发表论文 82 篇 · 总被引 2789 次 · h-index 22

代表论文

• The fatty acid receptor CD36 promotes macrophage infiltration via p110γ signaling to stimulate metastasis (2024 · Journal of Advanced Research · 被引 24)
• Guanidine‐Derived Polymeric Nanoinhibitors Target the Lysosomal V‐ATPase and Activate AMPK Pathway to Ameliorate Liver Lipid Accumulation (2024 · Advanced Science · 被引 10)
• Tislelizumab versus Sorafenib in First-Line Treatment of Unresectable Hepatocellular Carcinoma: Impact on Health-Related Quality of Life in RATIONALE-301 Study (2024 · Liver Cancer · 被引 9)
• 3-Hydroxypropionaldehyde modulates tryptophan metabolism to activate AhR signaling and alleviate ethanol-induced liver injury (2025 · Phytomedicine · 被引 8)
• CXCL12/CXCR4 modulates macrophage efferocytosis to induce glomerular crescent formation and fibrosis via ELMO1/DOCK180/RAC1 signaling in ANCA-associated glomerulonephritis (2025 · Cellular and Molecular Life Sciences · 被引 7)
• Hypoxia-responsive modules via tunable hydrophobicity reversal enhance renal-targeted release of CD36-interfering nanoparticles to ameliorate acute kidney injury (2025 · Journal of Controlled Release · 被引 4)